InoCardia
Coventry
About InoCardia
Inocardia is a Coventry University spinout focused on the provision of Contract Research Services via the development of assays targeted at the biotech and pharmaceutical sectors. Inocardia has developed the ‘work-loop’ model as a pre-clinical myocardial assay assessing cardiac contractility in normal, diseased and ageing myocardium in order to determine the cardiovascular safety of lead pharmaceutical compounds. The Coventry University work-loop assay is the only relevant in-vitro human model of cardio-toxicity available worldwide. Both the pharmaceutical industry and regulators recognise that contractility assessment is currently fraught with problems.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $391.0K
- Last round: Series Unknown (Jul 2014)
- Website: inocardia.co.uk
- Phone: +44 (0)7988 563489
Industries & Categories
Biopharma, Biotechnology, Life Science
Canonical: https://fsome.com/organization/inocardia-3137476 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.